一種新型縫合設(shè)備可以防止縫合針傷及外科醫(yī)生和手術(shù)室工作人員。

縫合針損傷的最常見原因是筋膜縫合，這是在大多數(shù)外科手術(shù)中必須縫合皮膚下面的一層。這在所有報(bào)道的手術(shù)損傷中占據(jù)59%。

360o筋膜縫合設(shè)備已經(jīng)獲得了美國食品藥品管理局的許可。這種獲得保護(hù)的設(shè)備可以防止縫合針損傷，將縫合針的尖端一直處于無菌的一次性縫合針筒之中，絕不會暴露出來。因此，手和手指在手術(shù)之前、之中和之后都不會暴露于縫合針的尖端?？p合方法比費(fèi)時(shí)費(fèi)力的手工縫合更加快速簡單和安全。這種縫合設(shè)備是SuturTek (North Chelmsford, MA, USA)公司的產(chǎn)品。

在美國和歐洲這種筋膜縫合設(shè)備已經(jīng)在各種手術(shù)中得到了廣泛應(yīng)用，包括腹部手術(shù)、剖腹產(chǎn)、經(jīng)腹部子宮切除、和脊柱手術(shù)。

“我們360o筋膜縫合設(shè)備的最關(guān)鍵之處，就是保護(hù)外科醫(yī)生、護(hù)士和手術(shù)室工作人員免于縫合針的傷害，這點(diǎn)從Johns Hopkins [Baltimore, MD, USA]的一項(xiàng)近期研究中可以得到佐證，他們報(bào)道40%的城市外科手術(shù)患者感染一些致命的疾病，例如肝炎或者HIV/AIDS,” SuturTek公司的總裁兼首席執(zhí)行官Gerald Brecher指出，“外科醫(yī)生告訴我們，這種產(chǎn)品不僅安全，而且快速，易于操作，能夠確保高質(zhì)量的臨床預(yù)后。”

Closure Device Prevents Injuries
 
A new closure device is designed to prevent suture needlestick injuries to surgeons and operating room (OR) staff.

The most common cause of suture needlestick injury is fascia closure, closure of the underlying layer below the skin that must be closed at the conclusion of most major surgical procedures. This accounts for 59% of all reported sharps injuries in the OR.

The 360o Fascia Closure Device has been cleared by the U.S. Food and Drug Administration (FDA). The patented device protects against suture needlestick injuries by ensuring that the sharp point of the suture needle--contained within a sterile, disposable suture cartridge at all times--is never exposed. Therefore, hands and fingers are not exposed to the sharp point of the needle before, during, or after the procedure. Closure is faster, easier, and safer for surgeons than tedious and difficult hand-suturing. The closure device is the product of SuturTek (North Chelmsford, MA, USA).

The Fascia Closure Device has been used in a wide variety of surgical procedures in the United States and Europe, including abdominal surgeries, cesarian deliveries, abdominal hysterectomies, and spinal surgery.

“The critical importance of our 360o Fascia Closure Device, that protects surgeons, nurses, and OR staff against needlesticks, is underscored by a recent study from Johns Hopkins [Baltimore, MD, USA] reporting that almost 40% of urban surgery patients are infected with deadly diseases such as hepatitis or HIV/AIDS,” noted Gerald Brecher, president and CEO of SuturTek. “And surgeons tell us that our device is not only safe, but it’s also fast, easy to use, and delivers high quality clinical results.”